HBP — Helix Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Helix Biopharma, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

	2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	3.56	3.25	0.808	1.08	0.065
Net Total Accounts Receivable
Net Total Receivables	0.353	0.279	0.062	0.054	0.121
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.02	3.69	0.996	1.46	0.409
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.047	0.036	0.033	0.033	—
Net Intangible Assets
Other Long Term Assets
Total Assets	4.07	3.73	1.03	1.49	18.8
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.87	3.41	1.87	1.58	3.22
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	5.46	3.41	1.87	1.58	—
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-1.39	0.319	-0.844	-0.09	15.6
Total Liabilities & Shareholders' Equity	4.07	3.73	1.03	1.49	18.8
Total Common Shares Outstanding